Evidence map›Paper›PMID 25477280›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2015

The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration.

Woo Kyun Bae, Keunsoo Kang, Ji Hoon Yu, Kyung Hyun Yoo, Valentina M Factor, Kosuke Kaji, Matthias Matter, Snorri Thorgeirsson, Lothar Hennighausen

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Enolase and 16.5-kDa Tegument-Associated Protein inJournal of extracellular biology · 2025
    Article
  6. Cell atlas of CClZoological research · 2023
    Article
  7. Review
  8. Fibrosis-the tale of H3K27 histone methyltransferases and demethylases.Frontiers in cell and developmental biology · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. EZH2 as a Potential Target for NAFLD Therapy.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Woo Kyun Bae*Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, and Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea; Department of Microbiology, Dankook University, Cheonan, Korea; and New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea drwookyun@chonnam.ac.kr lotharh@mail.nih.gov.
Keunsoo Kang*Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, and Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea; Department of Microbiology, Dankook University, Cheonan, Korea; and New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea.
Ji Hoon Yu*Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, and Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea; Department of Microbiology, Dankook University, Cheonan, Korea; and New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea.
Kyung Hyun Yoo*Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, and Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea; Department of Microbiology, Dankook University, Cheonan, Korea; and New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea.
Valentina M Factor*Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, and Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea; Department of Microbiology, Dankook University, Cheonan, Korea; and New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea.
Kosuke Kaji*Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, and Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea; Department of Microbiology, Dankook University, Cheonan, Korea; and New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea.
Matthias Matter*Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, and Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea; Department of Microbiology, Dankook University, Cheonan, Korea; and New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea.
Snorri Thorgeirsson*Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, and Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea; Department of Microbiology, Dankook University, Cheonan, Korea; and New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea.
Lothar Hennighausen*Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, and Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea; Department of Microbiology, Dankook University, Cheonan, Korea; and New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea drwookyun@chonnam.ac.kr lotharh@mail.nih.gov.
National Institute of Diabetes and Digestive and Kidney Diseases · USNational Institutes of Health · USCenter for Cancer Research · USChonnam National University · KRDankook University · KR

Funding

Genetic Approaches To Understanding Organ Development and FunctionZIADK061000 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HENNIGHAUSEN, LOTHAR · 2009 to 2025
$24.7M
Genomics Core FacilityZICDK071001 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2023
$16.6M
Epigenetic control by cytokines through STAT transcription factorsZIADK075030 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HENNIGHAUSEN, LOTHAR · 2009 to 2015
$4.1M
Intramural NIH HHS
6 · The paper itself

Abstract

To investigate the role of enhancer of zeste homolog (EZH) 1 and EZH2 in liver homeostasis, mice were generated that carried Ezh1(-/-) and EZH2(fl/fl) alleles and an Alb-Cre transgene. Only the combined loss of EZH1 and EZH2 in mouse hepatocytes caused a depletion of global trimethylation on Lys 27 of histone H3 (H3K27me3) marks and the specific loss of over ∼1900 genes at 3 mo of age. Ezh1(-/-),Ezh2(fl/fl)Alb-Cre mice exhibited progressive liver abnormalities manifested by the development of regenerative nodules and concomitant periportal fibrosis, inflammatory infiltration, and activation of A6-positive hepatic progenitor cells at 8 mo of age. In response to chronic treatment with carbon tetrachloride, all experimental mice, but none of the controls (n = 27 each), showed increased hepatic degeneration associated with liver dysfunction and reduced ability to proliferate. After two-thirds partial hepatectomy, mutant mice (n = 5) displayed increased liver injury and a blunted regenerative response. Genome-wide analyses at 3 mo of age identified 51 genes that had lost H3K27me3 marks, and their expression was significantly increased. These genes were involved in regulation of cell survival, fibrosis, and proliferation. H3K27me3 levels and liver physiology were unaffected in mice lacking either EZH1 globally or EZH2 specifically in hepatocytes. This work demonstrates a critical redundancy of EZH1 and EZH2 in maintaining hepatic homeostasis and regeneration.

Indexed as

AnimalsBiomarkersBlotting, WesternCell ProliferationCells, CulturedEnhancer of Zeste Homolog 2 ProteinFibrosisFluorescent Antibody TechniqueHepatocytesHigh-Throughput Nucleotide SequencingHistonesHomeostasisInflammationLiver RegenerationMaleMiceBiomarkersEnhancer of Zeste Homolog 2 ProteinEzh1 protein, mouseEzh2 protein, mouseHistonesPolycomb Repressive Complex 2RNA, MessengerfibrosisH3-K27 trimethylationliver regeneration

Identifiers

PMID25477280
PMCPMC4415007
OpenAlexW2121596297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.